Every public mention, peer-reviewed paper and award. Filter by category or read the full archive.
Aging Cell
Ponce De Leon Health highlights publication of a landmark peer-reviewed study in Aging Cell showing Rejuvant is associated with an average 1.8 year lower age residual — the only supplement to achieve statistical significance among 84 tested.
Read articleEarlier Coverage · 21 of 22
A randomized retrospective study of 42 individuals published in Aging shows Rejuvant, a patent-pending, timed-release CaAKG (calcium alpha-ketoglutarate) plus vitamin A for men and vitamin D for women, decreases biological age by an average of eight years after approximately seven months.
The search continues for possible interventions that delay and/or reverse biological aging, resulting in extended healthspan and lifespan. Interventions delaying aging in animal models now lead us to evaluate their potential in humans.
In the last century, the average human life expectancy doubled. Here's a roadmap to the innovations that could help us do it again - maybe. Rejuvant is the only commercially available product with data showing a positive effect on healthspan and lifespan.
A recent study suggests calcium alpha-ketoglutarate could positively affect aging, with increases in lifespan, a reduction in frailty, and increase in healthspan.
MD News Daily reports on the dietary supplement Rejuvant, found to promote healthy aging and increased life span in the landmark Buck Institute study - the first evidence of a non-drug ingredient achieving this result in mammals.
Science Magazine covers the landmark Buck Institute study showing that alpha-ketoglutarate, a compound used by bodybuilders, promotes healthy aging and extends life span in mice.
We use cookies to enhance your experience, analyze site usage, and provide personalized content. You can choose to accept all cookies or reject non-essential ones. For more details, see our Privacy Policy.
